WoE Analysis and Key Risk Factors in Preclinical Development of Medicinal Products: A Review
INTRODUCTION. In recent years, the Russian Federation and the Eurasian Economic Union have included the concept of ‘weight of evidence’ (WoE) in regulatory documents. International regulators place great emphasis on data transparency in documenting and assessing the WoE, and their position is reflec...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2024-12-01
|
| Series: | Безопасность и риск фармакотерапии |
| Subjects: | |
| Online Access: | https://www.risksafety.ru/jour/article/view/463 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|